Table 2.
Characteristics of studies (n=7) on follow-up
| Follow-up | FDG-PET | FDG-PET/CT | ||
|---|---|---|---|---|
|
| ||||
| Characteristics: | Number of studies | % of all studies on FDG-PET | Number of studies | % of all studies on FDG-PET/CT |
| Subjects, n: | ||||
| ≥35 | 1 | 50 | 4 | 80 |
| ≤35 | 1 | 50 | 1 | 20 |
| Design: | ||||
| Randomized | 0 | 0 | 0 | 0 |
| Prospective | 1 | 50 | 3 | 60 |
| Retrospective | 1 | 50 | 2 | 40 |
| Interpretation: | ||||
| SUV | 0 | 0 | 0 | 0 |
| Visual | 1 | 50 | 3 | 60 |
| SUV + visual | 1 | 50 | 1 | 20 |
| NA | 0 | 0 | 1 | 20 |
| Blinding | 0 | 0 | 1 | 20 |
| Not blinded | 2 | 100 | 2 | 40 |
| NA | 0 | 0 | 0 | 40 |
| Sufficient data to make 2x2 table | 1 | 50 | 5 | 100 |
| Not sufficient data to make 2x2 table | 1 | 50 | 0 | 0 |
| Total | 2 | 100 | 5 | 100 |
FDG, fluorodeoxyglucose; NA, not available; PET, Positron Emission Tomography; SUV, Standardized uptake value.